<VariationArchive VariationID="183391" VariationName="NM_004064.5(CDKN1B):c.59_77dup (p.Ser27fs)" VariationType="Duplication" Accession="VCV000183391" Version="4" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-01-26" DateCreated="2017-05-12" MostRecentSubmission="2024-01-26">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="181495" VariationID="183391">
      <GeneList>
        <Gene Symbol="CDKN1B" FullName="cyclin dependent kinase inhibitor 1B" GeneID="1027" HGNC_ID="HGNC:1785" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>12p13.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="12717368" stop="12722369" display_start="12717368" display_stop="12722369" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="12870301" stop="12875304" display_start="12870301" display_stop="12875304" Strand="+" />
          </Location>
          <OMIM>600778</OMIM>
          <Haploinsufficiency last_evaluated="2020-07-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CDKN1B">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-07-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CDKN1B">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_004064.5(CDKN1B):c.59_77dup (p.Ser27fs)</Name>
      <CanonicalSPDI>NC_000012.12:12717896:CAGGCGGAGCACCCCAAGCC:CAGGCGGAGCACCCCAAGCCAGGCGGAGCACCCCAAGCC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>12p13.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="12717896" stop="12717897" display_start="12717896" display_stop="12717897" variantLength="19" positionVCF="12717896" referenceAlleleVCF="G" alternateAlleleVCF="GCAGGCGGAGCACCCCAAGC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="12870830" stop="12870831" display_start="12870830" display_stop="12870831" variantLength="19" positionVCF="12870830" referenceAlleleVCF="G" alternateAlleleVCF="GCAGGCGGAGCACCCCAAGC" />
      </Location>
      <ProteinChange>S27fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.11" sequenceAccession="NC_000012" sequenceVersion="11" change="g.12870832_12870850dup" Assembly="GRCh37">
            <Expression>NC_000012.11:g.12870832_12870850dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.12" sequenceAccession="NC_000012" sequenceVersion="12" change="g.12717898_12717916dup" Assembly="GRCh38">
            <Expression>NC_000012.12:g.12717898_12717916dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_016341.1" sequenceAccession="NG_016341" sequenceVersion="1" change="g.5531_5549dup">
            <Expression>NG_016341.1:g.5531_5549dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004064.5" sequenceAccession="NM_004064" sequenceVersion="5" change="c.59_77dup" MANESelect="true">
            <Expression>NM_004064.5:c.59_77dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_004055.1" sequenceAccession="NP_004055" sequenceVersion="1" change="p.Ser27fs">
            <Expression>NP_004055.1:p.Ser27fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA186088" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="600778.0002" DB="OMIM" />
        <XRef Type="rs" ID="786201007" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff reviewed the sequence information reported in PubMed 17519308 Fig. 1A to determine the location of this allele on the current reference sequence.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_004064.5(CDKN1B):c.59_77dup (p.Ser27fs) AND Multiple endocrine neoplasia type 4" Accession="RCV000162205" Version="7">
        <ClassifiedConditionList TraitSetID="2430">
          <ClassifiedCondition DB="MedGen" ID="C1970712">Multiple endocrine neoplasia type 4</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2007-08-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2007-08-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2017-05-12" MostRecentSubmission="2024-01-26">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">17519308</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="2430" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3045" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Multiple endocrine neoplasia type 4</ElementValue>
                <XRef ID="MONDO:0012552" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MULTIPLE ENDOCRINE NEOPLASIA, TYPE IV</ElementValue>
                <XRef Type="MIM" ID="610755" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600778.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600778.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600778.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600778.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600778.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600778.0005" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MEN4</ElementValue>
                <XRef Type="MIM" ID="610755" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17275" />
                <XRef ID="17275" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Endocrine and Neuroendocrine Neoplasia genetics">
                <ID Source="PubMed">26389271</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">37733893</ID>
                <ID Source="BookShelf">NBK594826</ID>
              </Citation>
              <XRef ID="276152" DB="Orphanet" />
              <XRef ID="C1970712" DB="MedGen" />
              <XRef ID="MONDO:0012552" DB="MONDO" />
              <XRef Type="MIM" ID="610755" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="383266" SubmissionDate="2017-05-09" DateLastUpdated="2024-01-26" DateCreated="2015-03-16">
        <ClinVarSubmissionID localKey="600778.0002_MULTIPLE ENDOCRINE NEOPLASIA, TYPE IV" title="CDKN1B, 19-BP DUP, NT59_MULTIPLE ENDOCRINE NEOPLASIA, TYPE IV" />
        <ClinVarAccession Accession="SCV000212162" DateUpdated="2024-01-26" DateCreated="2015-03-16" Type="SCV" Version="4" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2007-08-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a Dutch woman with multiple endocrine neoplasia type IV (MEN4; 610755), Georgitsi et al. (2007) identified a heterozygous 19-bp duplication in exon 1 of the CDKN1B gene (c.59_77dup19), resulting in a frameshift and premature termination. The patient developed small-cell neuroendocrine cervical carcinoma, an ACTH-secreting pituitary adenoma, and hyperparathyroidism in her forties. She was also diagnosed with multiple sclerosis. Tumor tissue from the cervical carcinoma showed loss of heterozygosity for the wildtype allele and negative immunostaining for the p27 protein.</Attribute>
              <Citation>
                <ID Source="PubMed">17519308</ID>
              </Citation>
              <XRef DB="OMIM" ID="610755" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CDKN1B" />
          </GeneList>
          <Name>CDKN1B, 19-BP DUP, NT59</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">19-BP DUP, NT59</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="600778.0002" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">MULTIPLE ENDOCRINE NEOPLASIA, TYPE IV</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="383266" TraitType="Disease" MappingType="Name" MappingValue="MULTIPLE ENDOCRINE NEOPLASIA, TYPE IV" MappingRef="Preferred">
        <MedGen CUI="C1970712" Name="Multiple endocrine neoplasia type 4" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

